RecruitingNCT04062500
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)
Sponsor
Shanghai 10th People's Hospital
Enrollment
10,500 participants
Start Date
Jan 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria2
- \- 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.
- \. Agree to be tested and sign an informed consent certificate.
Exclusion Criteria1
- \. Age\<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.
Interventions
OTHERMortality and Rehospitalization rate
Mortality and Re-hospitalization of acute decompensated heart failure
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04062500
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location